NCT05288790RecruitingPhase 2
Microbiome Metabolites and Alcohol in HIV to Reduce CVD RCT
Source: ClinicalTrials.gov · Last updated 27 Aug 2026
Brief summary (registry, in English)
Among people living with HIV, heavy drinking increases the risk of heart disease and death. Studies suggest that alcohol changes the number and kind of bacteria in your gut and these changes increase the risk of heart disease and death. This randomized controlled trial will determine whether a pill containing healthy gut bacteria can increase the number good bacteria in the gut, lower levels of inflammation, and lower the risk of heart disease and death.
- Status (registry)
- Recruiting
- Phase (registry)
- Phase 2
- Study type
- Interventional
- Enrollment
- 250 (estimated)
- First submitted
- 28 Feb 2022
- Start date
- 18 Sept 2023
- Primary completion date
- 31 Mar 2027
- Lead sponsor
- Vanderbilt University Medical Center
- Diseases
- HIV
- NCT number
- NCT05288790
What you commit to
- Study type: Interventional · Phase 2
- Planned participants: 250
- From 18 Sept 2023 to the primary completion date, 31 Mar 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Not fluent in English
Who the study is looking for
- HIV infected
Age in the registry: 18 years to 89 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Vanderbilt University Medical Center Coordinator of this site? Confirm its status | Nashville | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.